Founded in 2015 and based in San Francisco, CA and Cambridge, MA, Cricket Health delivers value-based care for patients with chronic kidney disease and ESKD. Its StageSmart™ predictive analytics model identifies patients in stage 3b and beyond with 96 percent accuracy, enabling risk stratification for plans and providers. The company provides stage-specific care through MyCricket™, a comprehensive patient support service that includes a multidisciplinary care team, peer support, and virtual, telephone, or in-person resources. Cricket Health reports that its evidence-based approach increases transplant referrals, raises utilization of home dialysis, and reduces unnecessary hospitalizations for patients who progress to ESKD. The company intends to use the new funding for rapid expansion to meet demand for its care model across the United States. With the Series B, Cricket has raised more than $120 million in equity and debt financing to date. Cricket Health provides personalized, evidence-based care for chronic kidney disease (CKD) and end-stage renal disease (ESRD) through a multidisciplinary care team. The company partners with payers and providers to identify at-risk patients, intervene early to slow disease progression, and educate patients about treatment options. If patients progress to ESRD, Cricket supports transplant, home dialysis, conservative care, or in-center dialysis. Cricket has signed payer deals in California with Blue Shield of California and Cigna and says it serves patients in current markets including California and Texas, with plans to expand to other states. In October 2020 the company received $15 million in debt financing from K2 HealthVentures to support growth, add payer customers, and support more nephrology practices. Founded in 2015 and based in San Francisco and Cambridge, Cricket's leadership includes experts in nephrology, health care, and technology. Cricket Health provides tech-enabled integrated nephrology and dialysis care to CKD and ESRD patients, working with risk-bearing payers and health systems to identify high-risk patients before kidney failure. Founded in 2015 and based in San Francisco, the company focuses on preserving kidney function and delaying progression to dialysis. Its care model combines a nephrology practice (remote, in-person, and at-home care), a multidisciplinary care team, patient education and 24/7 peer and clinical support technology, and dialysis delivered at home or in redesigned centers. Treatment priorities include slowing kidney-failure progression, keeping patients out of the hospital, ensuring prepared transitions, and supporting patients on any ESRD treatment path. Cricket plans to use new funding to expand tech-enabled programs and its clinical presence, further develop care management for ESRD patients to delay dialysis, and create new home dialysis and in-center programs. Recent leadership additions include Chief Medical Officer Carmen A. Peralta, MD, MAS, and Chief Business Officer Danny Shapiro; medical advisors include Glenn Chertow, Michael Shlipak, and Joel Glickman. Cricket Health provides scalable solutions for patients managing advanced-stage CKD and ESRD, including patient education and clinical support. Its first product, Health Options Patient Education (HOPE), connects advanced-stage CKD patients to content, clinical expertise and a network of healthcare professionals, peers and mentors. The company is also developing machine-learning algorithms to identify persons with CKD within hospitals' electronic health record data. In addition, Cricket is building knowledge-rich decision-support systems to improve CKD management across the patient journey. Leadership includes co-founder and CEO Arvind Rajan and co-founder Vince Kim. The company completed a $2.5M seed funding round reported in October 2016.

Total raised

$125M

Funding rounds

4

Latest round

Series B

Latest activity

Aug 2021